pharmacophore for compounds active against Ebola
What is it about?
Two HTS screens identified some antimalarials and SERMs as active against Ebola. This paper explores if the molecules share similarities that could allow them to interact with the same target. This paper explores computational approaches such as pharmacophores and docking. VP35 has crystal structures of ligands and the molecules share some overlap with the 4 compounds used in the pharmacophore.
Why is it important?
Screening against the virus does not provide information on the potential target. No one had looked at similarity overlap of antimalarials and SERMSs or possible targets.
The following have contributed to this page: Dr Sean Ekins